动态计算机断层扫描测量肝神经内分泌肿瘤转移灶大小的最佳期相:平扫与增强期相的比较
本研究在44例病理确诊的神经内分泌肿瘤肝转移患者中,由两名盲法阅片者在平扫、动脉期和门静脉期图像上两次测量79个靶病灶的最长径,评估观察者间和观察者内一致性。结果显示平扫的一致性最高,其次为门静脉期,动脉期最低;平均肿瘤直径按期相从小到大依次为平扫、门静脉期、动脉期。作者认为若准确性得到证实,平扫CT可能是测量NET肝转移灶的最佳选择。
要点
- 平扫CT测量NET肝转移灶大小的观察者间和观察者内一致性均优于动脉期和门静脉期。
- 观察者间95%一致性界限:平扫-6.1~5.7 mm,门静脉期-7.9~7.1 mm,动脉期-8.5~7.4 mm。
- 平均肿瘤直径按期相从小到大依次为平扫、门静脉期、动脉期。
核心结论
- 平扫CT上测量NET肝转移灶大小的观察者间和观察者内一致性优于动脉期和门静脉期;若准确性得到证实,平扫CT可能是测量NET肝转移灶的最佳选择。
研究设计与样本
- 研究纳入44例连续病理确诊的NET肝转移患者,由研究协调员按RECIST 1.1标准选择靶病灶,两名盲法阅片者间隔4周两次测量平扫、动脉期和门静脉期图像上靶病灶的最长径。
关键影像表现/征象
- 79个靶病灶(近似平均大小3 cm)中45个表现为边缘强化。
- 动脉期或门静脉期图像上短暂、多变的边缘强化可能妨碍不同阅片者测量肝NET转移灶大小的可靠性。
诊断标准与关键数值
- 观察者间一致性按95%一致性界限评估:平扫CT为-6.1~5.7 mm,门静脉期为-7.9~7.1 mm,动脉期为-8.5~7.4 mm。
- 观察者内一致性:阅片者1平扫CT为-2.8~2.9 mm、门静脉期为-2.8~2.9 mm、动脉期为-3.2~4.2 mm;阅片者2平扫CT为-2.9~2.9 mm、门静脉期为-3.0~3.2 mm、动脉期为-3.4~3.2 mm。
- 平均肿瘤直径在各期相间差异显著,按期相从小到大依次为平扫CT、门静脉期、动脉期。
临床应用与阅片要点
- 作者认为若准确性得到证实,平扫CT可能是测量NET肝转移灶的最佳选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The reliability of size measurements of liver metastases from neuroendocrine tumors (NETs) on contrast-enhanced computed tomography (CT) phases made by different readers may be hampered due to transient, variable rim enhancement in arterial phase (AP) or portal venous phase (PVP) images. We aimed to assess the reliability of tumor size measurements in pre- and post-contrast scans.
MATERIALS AND METHODS: The study coordinator selected target lesions according to Response Evaluation Criteria in Solid Tumors 1.1 guidelines in 44 consecutive patients with pathologically confirmed NET liver metastases. Two blinded readers measured the longest diameters of target lesions on pre-contrast, AP, and PVP images twice with a 4-week interval. Inter- and intra-observer agreements were evaluated using Bland-Altman plots and 95% limit of agreement (LOA) calculations.
RESULTS: Of the 79 target lesions (approximate mean size of 3 cm), 45 showed rim enhancement. Inter-observer agreement assessed based on LOA was highest in pre-contrast CT images (-6.1-5.7 mm), followed by PVP (-7.9-7.1 mm) and AP (-8.5-7.4 mm) images. Intra-observer agreement showed the same trend: -2.8-2.9 mm and -2.9-2.9 mm for readers 1 and 2, respectively, on pre-contrast CT, -2.8-2.9 mm and -3.0-3.2 mm, respectively, on PVP, and -3.2-4.2 mm and -3.4-3.2 mm, respectively, on AP images. Mean tumor diameters differed significantly among the phases in the following increasing order: pre-contrast CT, PVP, and AP images.
CONCLUSION: There was better inter- and intra-observer agreement in size measurements of NET liver metastases on precontrast scans than on AP and PVP scans. Pre-contrast CT may be the optimal for measuring NET liver metastases if its accuracy is proven.
引用
- Huh J, Park J, Kim KW, et al. Optimal Phase of Dynamic Computed Tomography for Reliable Size Measurement of Metastatic Neuroendocrine Tumors of the Liver: Comparison between Pre- and Post-Contrast Phases. Korean J Radiol. 2018. PMID: 30386138. doi:10.3348/kjr.2018.19.6.1066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。